Myxoma virus M141R expresses a viral CD200 (vOX-2) that is responsible for down-regulation of macrophage and T-cell activation in vivo

Journal of Virology

Volumn 79, Issue 10, 2005, Pages 6052-6067

  Cameron, Cheryl M ^a   Barrett, John W ^a   Liu, Liying ^a   Lucas, Alexandra R ^a   McFadden, Grant ^a  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD200 ANTIGEN; CELL SURFACE PROTEIN; GAMMA INTERFERON; INTERLEUKIN 2 RECEPTOR ALPHA; IONOMYCIN; NITRIC OXIDE SYNTHASE; PHORBOL 13 ACETATE 12 MYRISTATE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL LINEAGE; CONTROLLED STUDY; DELETION MUTANT; DOWN REGULATION; GENETIC CODE; LYMPHOID TISSUE; MACROPHAGE; MONONUCLEAR CELL; MYXOMA VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; STRAIN DIFFERENCE; T LYMPHOCYTE ACTIVATION; VIRUS GENE; VIRUS INFECTION; VIRUS REPLICATION; VIRUS STRAIN;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, VIRAL; CELL LINE; DISEASE MODELS, ANIMAL; DOWN-REGULATION; FEMALE; LYMPH NODES; LYMPHOCYTE ACTIVATION; MACROPHAGE ACTIVATION; MOLECULAR SEQUENCE DATA; MYXOMA VIRUS; POXVIRIDAE INFECTIONS; RABBITS; SEQUENCE ALIGNMENT; TIME FACTORS; VIRAL PROTEINS; VIRULENCE FACTORS;

MYXOMA VIRUS; ORYCTOLAGUS CUNICULUS;

EID: 18144393023     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.10.6052-6067.2005     Document Type: Article

References (57)

1. Aktan, F. 2004. iNOS-mediated nitric oxide production and its regulation. Life Sci. 75:639-653.
2. Alcami, A., and U. H. Koszinowski. 2000. Viral mechanisms of immune evasion. Immunol. Today 21:447-455.
3. Altschul, S. F., W. Gish, W. Miller, E. W. Myers, and D. J. Lipman. 1990. Basic local alignment search tool. J. Mol. Biol. 215:403-410.
4. Banerjee, D., and A. D. Dick. 2004. Blocking CD200-CD200 receptor axis augments NOS-2 expression and aggravates experimental autoimmune uveoretinitis in Lewis rats. Ocul. Immunol. Inflamm. 12:115-125.
5. Barclay, A. N. 1981. Different reticular elements in rat lymphoid tissue identified by localization of Ia, Thy-1 and MRC OX 2 antigens. Immunology 44:727-736.
6. Barclay, A. N., M. J. Clark, and G. W. McCaughan. 1986. Neuronal/lymphoid membrane glycoprotein MRC OX-2 is a member of the immunoglobulin superfamily with a light-chain-like structure. Biochem. Soc. Symp. 51:149-157.
7. Barclay, A. N., G. J. Wright, G. Brooke, and M. H. Brown. 2002. CD200 and membrane protein interactions in the control of myeloid cells. Trends Immunol. 23:285-290.
8. Barrett, J., J.-X. Cao, S. Hota-Mitchell, and G. McFadden. 2001. Immunomodulatory proteins of myxoma virus. Semin. Immunol. 13:73-84.
9. Borriello, F., J. Lederer, S. Scott, and A. H. Sharpe. 1997. MRC OX-2 defines a novel T-cell costimulatory pathway. J. Immunol. 158:4548-4554.
10. Bukovsky, A., J. Presl, J. Zidovsky, and P. Mancal. 1983. The localization of Thy-1.1, MRC OX 2 and Ia antigens in the rat ovary and fallopian tube. Immunology 48:587-596.
11. Cameron, C., S. Hota-Mitchell, L. Chen, J. Barrett, J.-X. Cao, C. Macaulay, D. Willer, D. Evans, and G. McFadden. 1999. The complete DNA sequence of myxoma virus. Virology 264:298-318.
12. Chakrabarti, S., J. R. Sisler, and B. Moss. 1997. Compact, synthetic, vaccinia virus early/late promoter for protein expression. BioTechniques 23:1094-1097.
13. Chung, Y. H., R. E. Means, J. K. Choi, B. S. Lee, and J. U. Jung. 2002. Kaposi's sarcoma-associated herpesvirus OX2 glycoprotein activates myeloid-lineage cells to induce inflammatory cytokine production. J. Virol. 76:4688-4698.
14. De Paoli, P. 2004. Human herpesvirus 8: an update. Microbes Infect. 6:328-335.
15. Dourmishev, L. A., A. L. Dourmishev, D. Palmeri, R. A. Schwarts, and D. M. Lukac. 2003. Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) epidemiology and pathogenesis. Microbiol. Mol. Biol. Rev. 67:175-212.
16. Fallarino, F., C. Asselin-Paturel, C. Vacca, R. Bianchi, S. Gizzi, M. C. Fioretti, G. Trinchieri, U. Grohmann, and P. Puccetti. 2004. Murine plasmacytoid dendritic cells initiate the immunosuppressive pathway of tryptophan catabolism in response to CD200 receptor engagement. J. Immunol. 173:3748-3754.
17. Fenner, F. 1979. Portraits of viruses: the poxviruses. Intervirology 11:137-157.
18. Fenner, F., and F. N. Ratcliffe. 1965. Myxomatosis. Cambridge University Press, Cambridge, United Kingdom.
19. Foster-Cuevas, M., G. J. Wright, M. J. Puklavec, M. H. Brown, and A. N. Barclay. 2004. Human herpesvirus 8 K14 protein mimics CD200 in down-regulating macrophage activation through CD200 receptor. J. Virol. 78:7667-7676.
20. Gorczynski, L., Z. Chen, J. Hu, Y. Kai, J. Lei, V. Ramakrishna, and R. M. Gorczynski. 1999. Evidence that an OX-2-positive cell can inhibit the stimulation of type 1 cytokine production by bone marrow-derived B7-1 (and B7-2)-positive dendritic cells. J. Immunol. 162:774-781.
21. Gorczynski, R., J. Bransom, M. Cattral, X. Huang, J. Lei, W. Min, Y. Wan, and J. Gauldie. 2001. Dendritic cells expressing TGFbeta/IL-10, and CHO cells with OX-2, increase graft survival. Transplant. Proc. 33:1565-1566.
22. Gorczynski, R. M., M. S. Cattral, Z. Chen, J. Hu, J. Lei, W. P. Min, G. Yu, and J. Ni. 1999. An immunoadhesin incorporating the molecule OX-2 is a potent immunosuppressant that prolongs allo- and xenograft survival. J. Immunol. 163:1654-1660.
23. Gorczynski, R. M., Z. Chen, X. M. Fu, and H. Zeng. 1998. Increased expression of the novel molecule OX-2 is involved in prolongation of murine renal allograft survival. Transplantation 65:1106-1114.
24. Guzik, T. J., R. Korbut, and T. Adamek-Guzik. 2003. Nitric oxide and superoxide in inflammation and immune regulation. J. Physiol. Pharmacol. 54:469-487.
25. Hatherley, D., and A. N. Barclay. 2004. The CD200 and CD200 receptor cell surface proteins interact through their N-terminal immunoglobulin-like domains. Eur. J. Immunol. 34:1688-1694.
26. Hedrick, S. M. 2004. The acquired immune system: a vantage from beneath. Immunity 21:607-615.
27. Hilleman, M. R. 2004. Strategies and mechanisms for host and pathogen survival in acute and persistent viral infections. Proc. Natl. Acad. Sci. USA 101:14560-14566.
28. Hoek, R. M., S. R. Ruuls, C. A. Murphy, G. J. Wright, R. Goddard, S. M. Zurawski, B. Blom, M. E. Homola, W. J. Streit, M. H. Brown, A. N. Barclay, and J. D. Sedgwick. 2000. Down-regulation of the macrophage lineage through interaction with OX2 (CD200). Science 290:1768-1771.
29. Johnston, J. B., J. W. Barrett, W. Chang, C. S. Chung, W. Zeng, J. Masters, M. Mann, F. Wang, J. Cao, and G. McFadden. 2003. Role of the serinethreonine kinase PAK-1 in myxoma virus replication. J. Virol. 77:5877-5888.
30. Johnston, J. B., and G. McFadden. 2003. Poxvirus immunomodulatory strategies: current perspectives. J. Virol. 77:6093-6100.
31. Johnston, J. B., and G. McFadden. 2004. Technical knockout: understanding poxvirus pathogenesis by selectively deleting viral immunomodulatory genes. Cell. Microbiol. 9:695-705.
32. Karupiah, G., Q. W. Xie, R. M. Buller, C. Nathan, C. Duarte, and J. D. MacMicking. 1993. Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase. Science 261:1445-1448.
33. Kerr, P., and G. McFadden. 2002. Immune responses to myxoma virus. Viral Immunol. 15:229-246.
34. Moss, B. 2001. Poxviridae: the viruses and their replication, p. 2849-2883. In D. M. Knipe et al. (ed.), Fields virology, 4th ed., vol. 2. Lippincott Williams & Wilkins, Philadelphia, Pa.
35. Mossman, K., C. Upton, and G. McFadden. 1995. The myxoma virus-soluble interferon-γ receptor homolog, M-T7, inhibits interferon-7 in a species-specific manner. J. Biol. Chem. 270:3031-3038.
36. Nathan, C., and W. A. Muller. 2001. Putting the brakes on innate immunity: a regulatory role of CD200. Nat. Immunol. 2:17-19.
37. Nicholas, J. 2003. Human herpesvirus-8-encoded signalling ligands and receptors. J. Biomed. Sci. 10:475-489.
38. Opgenorth, A., K. Graham, N. Nation, D. Strayer, and G. McFadden. 1992. Deletion analysis of two tandemly arranged virulence genes in myxoma virus, M11L and myxoma growth factor. J. Virol. 66:4720-4731.
39. Ormerod, A. D., M. I. White, S. A. Shah, and N. Benjamin. 1999. Molluscum contagiosum effectively treated with a topical acidified nitrite, nitric oxide liberating cream. Br. J. Dermatol. 141:1051-1053.
40. Rappuoli, R. 2004. From Pasteur to genomics: progress and challenges in infectious diseases. Nat. Med. 10:1177-1185.
41. Rolph, M. S., W. B. Cowden, C. J. Medveczky, and I. A. Ramshaw. 1996. A recombinant vaccinia virus encoding inducible nitric oxide synthase is attenuated in vivo. J. Virol. 70:7678-7685.
42. Rosenblum, M. D., E. B. Olasz, K. B. Yancey, J. E. Woodiff, Z. Lazarova, K. A. Gerber, and R. L. Truitt. 2004. Expression of CD200 on epithelial cells of the murine hair follicle: a role in tissue-specific immune tolerance? J. Investig. Dermatol. 123:880-887.
43. Sanders, S. P. 1999. Asthma, viruses, and nitric oxide. Proc. Soc. Exp. Biol. Med. 220:123-132.
44. Sanders, S. P., J. Kim, K. R. Connolly, J. D. Porter, E. S. Siekierski, and D. Proud. 2001. Nitric oxide inhibits rhinovirus-induced granulocyte macrophage colony-stimulating factor production in bronchial epithelial cells. Am. J. Respir. Cell Mol. Biol. 24:317-325.
45. Sanders, S. P., E. S. Siekierski, J. D. Porter, S. M. Richards, and D. Proud. 1998. Nitric oxide inhibits rhinovirus-induced cytokine production and viral replication in a human respiratory epithelial cell line. J. Virol. 72:934-942.
46. Sanders, S. P., E. S. Siekierski, S. M. Richards, J. D. Porter, F. Imani, and D. Proud. 2001. Rhinovirus infection induces expression of type 2 nitric oxide synthase in human respiratory epithelial cells in vitro and in vivo. J. Allergy Clin. Immunol. 107:235-243.
47. Seet, B. T., J. B. Johnston, C. R. Brunetti, J. W. Barrett, H. Everett, C. Cameron, J. Sypula, S. H. Nazarian, A. Lucas, and G. McFadden. 2003. Poxviruses and immune evasion. Annu. Rev. Immunol. 21:377-423.
48. Smet, E. G., W. De Smet, L. Brys, and P. C. De Baetselier. 1986. Mab. 198: a monoclonal antibody recognizing the complement type 3 receptor (CR3) in the rabbit. Immunology 59:419.
49. Strayer, D. S. 1989. Poxviruses, p. 173-192. In S. Specter, M. Bendinelli, and H. Friedman (ed.), Virus-induced immunosuppression. Plenum Press, New York, N. Y.
50. Tafalla, C., A. Figueras, and B. Novoa. 1999. Role of nitric oxide on the replication of viral haemorrhagic septicemia virus (VHSV), a fish rhabdovirus. Vet. Immunol. Immunopathol. 72:249-256.
51. Tafalla, C. A., A. Figueras, and B. Novoa. 2001. Viral hemorrhagic septicemia virus alters turbot Scophthalmus maximus macrophage nitric oxide production. Dis. Aquat. Organ. 47:101-107.
52. Webb, M., and A. N. Barclay. 1984. Localisation of the MRC OX-2 glycoprotein on the surfaces of neurones. J. Neurochem. 43:1061-1067.
53. Welsh, R. M., L. K. Selin, and E. Szomolanyi-Tsuda. 2004. Immunological memory to viral infections. Annu. Rev. Immunol. 22:711-743.
54. Wilkinson, J. M., G. McDonald, S. Smith, J. Galea-Lauri, J. Lewthwaite, B. Henderson, and P. A. Revell. 1993. Immunohistochemical identification of leucocyte populations in normal tissue and inflamed synovium of the rabbit. J. Pathol. 170:315-320.
55. Wright, G. J., H. Cherwinski, M. Foster-Cuevas, G. Brooke, M. J. Puklavec, M. Bigler, Y. Song, M. Jenmalm, D. Gorman, T. McClanahan, M. R. Liu, M. H. Brown, J. D. Sedgwick, J. H. Phillips, and A. N. Barclay. 2003. Characterization of the CD200 receptor family in mice and humans and their interactions with CD200. J. Immunol. 171:3034-3046.
56. Wright, G. J., M. J. Puklavec, A. C. Willis, R. M. Hoek, J. D. Sedgwick, M. H. Brown, and A. N. Barclay. 2000. Lymphoid/neuronal cell surface OX2 glycoprotein recognizes a novel receptor on macrophages implicated in the control of their function. Immunity 13:233-242.
57. Zhang, S., H. Cherwinski, J. D. Sedgwick, and J. H. Philips. 2004. Molecular mechanisms of CD200 inhibition of mast cell activation. J. Immunol. 173:6786-6793.